Knowledge | Gen Re

Individual Disability – Results of 2021 U.S. Market Survey

Disability | May 19, 2022| English

Summary of our industry benchmarking survey covering Non-Cancelable, Guaranteed Renewable, Buy-Sell and Guaranteed Standard Issue product line results. Full survey available only to participants, but sharing some information learned.

Political and Societal Unrest – What Are the Implications for Insurers?

Commercial Umbrella, Property | May 18, 2022| English

A change in seasons again brings hopeful signs that much of pre-pandemic life is returning. Current COVID‑19 variants, while more contagious, are less virulent than earlier variants. U.S. workers in many sectors are returning to offices under a new...

Opportunities Abound in the Small Commercial Marketplace – The Key to a Strong Distribution Strategy

P/C General Industry, Commercial Umbrella, Personal Umbrella | May 11, 2022| English

Part 2 in our series examining the Small Commercial marketplace and the five strategies insurers can utilize for profitable expansion into this market. As carriers look for profitable growth opportunities, many are looking to expand their offerings...

Recommended

The Depression Claims Wizard – A Gen Re Digital Tool for Depression Claims Management

By Dr. Sandra Mitic and Mary Enslin | May 12, 2022 | English

There is an ongoing focus on mental health claims crossing all continents and Life/Health products, and this has only intensified as a result of the COVID‑19 pandemic. A potential explanation for this development may be that the number of mental health...
Read More
2022: A Great Opportunity for the Disability Insurance Market

By Mike Krohn | May 03, 2022 | English

The COVID‑19 pandemic has caused all of us around the globe to rethink the paradigm around how we approach life. Many people have been asking novel and more complicated questions: How much socializing do I do in enclosed spaces? Should I work from home...
Read More
Trend Study on In-force Medical Business in China

By Chen Zhang and Xiaotian Yu | Apr 26, 2022 | English

“Million Medical Insurance”1 (百万医疗 in Chinese) is the fastest-growing commercial health insurance product in recent years, and its experience monitoring has raised keen concerns for Chinese insurers. It is well-known that medical inflation, portfolio...
Read More
Critical Illness in Asia – Product Evolution and its Implications

By Orchis Li | Apr 07, 2022 | English

Highlights from the Gen Re Dread Disease Survey We started offering Critical Illness (CI) products in the late 1980s and early 1990s, covering just seven diseases. This quickly increased to around 30 conditions and then more than 50 by the late 1990s. In...
Read More